- SEK15.67bn
- SEK17.95bn
- €425.00m
Brief: Vimian Q1 Adjusted EBITA EUR 29.2 Million Vs. IBES Estimate EUR 29.2 Million
Brief: Vimian Proposes To AGM In 2026 To Not Distribute Dividend For 2025
Brief: Vimian Acquires I-Vet
Brief: Vimian Group Appoints Alireza Tajbakhsh As CEO
Brief: Vimian Q3 Adjusted EBITA EUR 25.5 Million
Brief: Vimian Executive Sven Johan Magnus Göte Kjellberg Disposed SEK 2.2 Mln Worth Of Share
Europe Research Roundup: Alfen, Dermapharm Holding, Fugro
Brief: Vimian Q2 Adjusted EBITA EUR 25.4 Million
Brief: Vimian CEO Patrik Eriksson Steps Down
Brief: Vimian To Buy Allaccem Inc
Brief: Vimian Contemplates Issuance Of Senior Unsecured Bond
Brief: Vimian Group Q1 Adjusted EBITA Up At EUR 28.3 Mln
Brief: Vimian Q1 Adjusted EBITA EUR 28.3 Million
Brief: Vimian Has Been Approved For Listing On Nasdaq Stockholm
Brief: Vimian Q4 Adjusted EBITA EUR 24.6 Million
Brief: Vimian Q3 Adjusted EBITA EUR 21.9 Million
Brief: Vimian Group Acquires Global Veterinary Dental Company
Brief: Vimian Q2 Adjusted EBITA EUR 24.7 Million
Brief: Vimian Reaches Settlement Agreement With One Of Main Sellers Of Voi